Group 1 - The largest shareholder of Jinlitai, Hainan Dahe, is seeking support from all shareholders to remove three directors and elect a new one due to concerns over the company's management and potential delisting risks [1][2][3] - Hainan Dahe has publicly stated that Jinlitai is at high risk of delisting and accused the current board of misappropriating company funds [3][4] - There are ongoing disputes within the company regarding the management's responses to inquiries, with significant disagreements among board members [4][14] Group 2 - Jinlitai's 2024 annual report revealed an audit report with no opinion, indicating internal issues and prompting regulatory scrutiny over potential non-operational fund occupation [7][8] - The company has been accused of transferring funds under the guise of a "strategic reserve," which may involve significant risks of fund misappropriation [10][13] - The audit committee has expressed that the strategic reserve actions do not align with normal procurement practices and should be classified as non-operational fund occupation [15] Group 3 - There are allegations of "false repayments" related to transactions with two entities, raising questions about the legitimacy of the funds' flow [18][20] - The audit committee suspects that repayments from one entity may have returned to the original fund provider, indicating potential financial manipulation [22][24] - Jinlitai's management has denied any wrongdoing, asserting that the transactions were legitimate despite the concerns raised by board members [21][22] Group 4 - The actual control of Jinlitai is under scrutiny, with claims that a mysterious individual, Pei Jian, may be the real controller behind the scenes [25][30] - There are connections between Pei Jian and a trading company accused of fund misappropriation, suggesting a complex web of control and influence [32][41] - Internal sources indicate that Pei Jian has significant influence over the company's operations, despite the official stance that there is no actual controller [41][42]

Core Viewpoint - *ST Jintai is facing scrutiny over nearly 1.5 billion yuan in abnormal fund flows, with significant discrepancies between the funds paid to suppliers and actual procurement needs, raising concerns about potential non-operational fund occupation and mismanagement [1][3][10] Group 1: Abnormal Fund Flows - In 2024, *ST Jintai reported nearly 1.5 billion yuan in abnormal fund flows, including over 900 million yuan for "strategic inventory" and 460 million yuan in equity investment payments [3][4] - The company disclosed that the actual procurement amount was only about 29 million yuan, indicating a severe mismatch between funds transferred and actual purchases [3][4] - The strategic inventory funds were transferred to suppliers, who then moved the funds to non-supplier entities, suggesting potential misuse of funds [3][6] Group 2: Strategic Inventory Practices - The company initiated a "strategic inventory" strategy to mitigate raw material price risks, but the audit committee found that this practice no longer aligned with normal procurement principles [2][7] - The actual procurement conversion rate from strategic inventory was less than 4%, with significant costs incurred from fund occupation [3][6] - The strategic inventory suppliers, particularly Rui Nai and Yue Rui, accounted for over 85% of the payments in 2024, indicating a concentrated risk in supplier relationships [6][8] Group 3: Equity Investment Transactions - The company engaged in two equity transactions involving Yitai Ji, with a total of 460 million yuan in payments, raising questions about the true purpose and flow of these funds [4][10] - The audit committee suggested that the funds for these transactions were linked to the strategic inventory, indicating potential non-operational fund occupation [10][11] - Concerns were raised about the flow of funds from related parties, with allegations of a closed-loop system that could lead to asset misappropriation [11][12] Group 4: Governance and Internal Disputes - Three board members opposed the company's responses to regulatory inquiries, citing concerns over management's handling of funds and potential collusion with actual controllers [1][8] - The audit committee highlighted discrepancies in the company's disclosures regarding supplier relationships and fund flows, suggesting a lack of transparency [7][8] - The company claimed no controlling shareholder exists, despite evidence suggesting that key suppliers are linked to the same controlling entity [8][12]

Core Viewpoint - *ST Jintai is facing scrutiny over nearly 1.5 billion yuan in abnormal fund flows, with significant discrepancies between procurement needs and actual expenditures, raising concerns about potential non-operational fund occupation and mismanagement [3][7][11]. Group 1: Abnormal Fund Flows - In 2024, *ST Jintai reported nearly 1.5 billion yuan in abnormal fund flows, including over 900 million yuan for "strategic inventory" and 460 million yuan in equity investments [7][8]. - The company engaged in a "seasonal transfer" of funds, with 9.31 billion yuan transferred out and the same amount returned, while actual procurement amounted to only about 29 million yuan, indicating a severe mismatch [7][10]. - The strategic inventory funds were primarily funneled through suppliers like Ruinai and Yue Rui, which received over 85% of the total payments in 2024 [10][11]. Group 2: Strategic Inventory Practices - The strategic inventory initiative, started in 2022, aimed to secure raw material supply and lock in prices, but the actual procurement ratio has drastically declined from 78.12% in 2022 to just 3.18% in 2024 [10][11]. - The cost of capital for these strategic inventory practices has increased significantly, with costs rising from 136.26 thousand yuan in 2022 to 756.05 thousand yuan in 2024 [10][11]. - The audit committee expressed concerns that the strategic inventory behavior in 2024 did not align with normal procurement practices and was likely aimed at manipulating financial reports [4][5][11]. Group 3: Equity Investment Anomalies - The company made two significant equity investments in Shenzhen Yitai Technology Co., totaling 460 million yuan, with unclear final destinations for these funds [3][8][16]. - The audit committee noted that the funds from these equity transactions appeared to be funneled back into the strategic inventory, suggesting a potential cycle of non-operational fund occupation [16][17]. - There are allegations that the funds from these transactions were used to mask the true financial state of the company, with claims of collusion among various parties involved [17][18].

大额采购资金经8家贸易商"季度循环"、股权投资的资金去向不明，*ST金泰（300225.SZ）近15亿资金 异常流转的问询回复陷入争议。 *ST金泰在8月12日披露的监管问询回复中称，2024年，该公司为规避原材料价格上涨风险，采取"战略 备库"措施，向贸易商支付超9亿元资金，实际采购金额仅2900余万元，资金流向与采购需求严重背离。 其中，供应商部分资金流向非经营实体，与芮奈贸易（上海）有限公司（下称"芮奈"）的资金往来涉嫌 存在非经营性资金占用情况。 不仅如此，*ST金泰去年还向深圳怡钛积科技股份有限公司（下称"怡钛积"）支付了两笔股权投资款， 合计金额4.6亿元，资金最终流向的、真实目的不明。但该公司一名董事长称，这些资金中的大部分， 经层层划转，最终流向了配资公司。 根据公告，该公司2024年战略备库预付款转化的实际采购（转化率）不足4%，实际占用资金成本为 756.05万元，实际采购节约成本184.73万元，扣除资金占用成本后，实际亏损571.32万元。 在2024年战略备库已经遭受损失的情况下，该公司今年仍然存在向芮奈等5家供应商转出及转回资金的 情况，合计预付款2.56亿元，退款1.21亿元，采 ...